The importance for PKC activity to the cardiac phenotype observed in a mouse model for myotonic dystrophy type 1 was explored by treating the animals with Ro-31-8220, a PKC inhibitor of the bisindolylmaleimide class. The gene discussed is PRRT2; the disease is myotonic dystrophy type 1.